Life Science Supplier Qualification Best Practices Training Course: Strengthen Compliance and Quality Systems, Navigate Complex Supplier Qualification Processes (ONLINE EVENT: July 16-17, 2025)
Strengthen your pharmaceutical, biotech, and medical device quality systems through comprehensive supplier qualification and audits. Navigate regulatory demands with expert strategies and crucial resources, including SOPs, risk audit templates, and quality agreements. Enhance compliance and optimize performance with CPD-certified training.
Best Practices for Supplier Qualification in Life Science Training Course
Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Best Practices for Supplier Qualification in Life Science Training Course" training has been added to ResearchAndMarkets.com's offering.
This course equips participants with practical strategies to navigate complex supplier qualification processes, enhancing compliance, and optimizing quality management systems to meet stringent regulatory expectations.
Conduct thorough supplier qualifications and audits to strengthen the quality systems of your pharmaceutical, biotechnology, and medical device manufacturing processes.
Ensuring suppliers consistently meet quality requirements is paramount across all materials and services procured. Regulatory agencies such as FDA, EMA, MHRA, TGA, PIC/S, and ISO 13485 have intensified their focus on supplier qualification. The 2015 update of the EU GMP Guide notably emphasised supplier selection and qualification in Chapter 5, marking a significant regulatory shift.
While supplier qualification may have been unfamiliar decades ago, it has now become integral to industry practices. Qualifying suppliers, especially those in regions like China and India, presents unique challenges, demanding additional responsibilities for both parties. Beyond audits, establishing effective "Quality Agreements" is essential. Prior to outsourcing, companies must define minimum product specification and user requirements to ensure compliance with GMP standards. Each product may necessitate specific evaluation criteria during initial technical visits to potential supplier, involving assessment of SOPs, Quality Management Systems, previous audits, organisational structure, and task distribution.
Delegates will gain comprehensive strategies and insights into conducting rigorous supplier qualification and audits to enhance the quality systems across pharmaceutical, biotechnology, and medical device manufacturing processes.
Bonus documents included:
Supplier qualification questionaries (API, excipient, packaging material)
Supplier evaluation matrix
Risk-based supplier audits
Quality Agreement
Supplier qualification sample SOP
FDA inspection findings, example warning letters, Form 483s
Warehouse, logistics service provider qualification documents
Benefits of attending
Learn supplier source search criteria
Understand key considerations in supplier selection
Develop skills in preparing supplier pre-evaluation questionnaires
Discuss strategies to overcome constraints in supplier audits
Formulate effective performance evaluations for suppliers
Gain insights into evaluating suppliers from different perspectives
Witness exemplary practices in pharmaceutical and medical device industries, exceeding health authority and GMP expectations.
Certifications:
CPD: 12 hours for your records
Certificate of completion
Who Should Attend:
Quality Assurance/Quality Control Specialists
GMP Compliance Officers
Validation Professionals
Engineering Personnel
Operation Staff
Manufacturing Professionals
Supply Chain
Logistics Staff
IT Personnel
Purchasing Managers
Key Topics Covered:
Day 1
Supplier Qualification Introduction
What is supplier qualification?
Why should qualification be done, who requires/expects It?
International guidelines and directives for supplier qualification
Overview of legislation, health authority expectations
International Trade Laws
Is the ISO 9001 certificate only sufficient for supplier qualification?
Why should the purchasing unit receive GMP training?
What should be the scope of training?
Quality Management System and supplier qualification
What is change control?
How should deviations be managed?
How are complaints, recalls, and supplier qualification related?
What is the role and importance of purchasing in supplier qualification?
Can quality assurance, supplier, and purchasing cooperation be achieved?
Sampling and test reduction
What does reduced testing mean?
What are the health authority expectations for reduced testing?
What should be done before test reduction?
Raw materials and service providers
Should active pharmaceutical ingredients (APIs) and excipients be evaluated using the same method?
How to qualify service providers?
Medical device suppliers
Medical device supplier qualification process (21 CFR Part 820, MDR, GHTF, ISO 9001, ISO 1497, ISO 13485)
PIP breast implant scandal
Flow of supplier qualification & documentation
How does the relationship between audits and supplier qualification begin?
Who performs qualification activities?
How do we know who does what - Manufacturer or Distributor?
How will we document our supplier qualification activities?
What is the qualification cycle?
Group exercise: Review of an existing supplier categorisation and evaluation study
Critique of format
Critique of content
Workshop: Supplier categorisation & evaluation
Breakout groups to review and suggest improvement in the selection of supplier categorisation and evaluations.
Day 2
Supplier auditing
Why are audits necessary and critical?
Risk-based audit planning.
To audit or not to audit?
What should the frequency of supplier audits be?
Different approaches to different suppliers
Quality agreement preparation
What are Quality Agreements and why are they needed?
What should and should not be included in quality agreements?
Tips for negotiating an agreement.
How to troubleshoot common deficiencies?
Who prepares and approves the quality agreement? / Roles - What are the responsibilities?
Supply chain risk management
How should unexpected incidents be managed?
How to apply risk management in supply chain? Cases
What to consider when purchasing from Asian countries?
How to overcome cultural difference problems in purchasing from India and China?
How should we audit in India and China?
What are the most common quality deficiencies?
What is the latest situation of the pharmaceutical market in India and China? (Legal Requirements, Authority Approaches)
What are the GMP violations in China and India?
What about audits in Europe and Latin America?
Which documents are enough to make a company legal/illegal?
Supply chain risk mitigation strategies.
Supplier qualification and digital technologies
Group exercise: Review of an existing supplier Quality Agreement
Critique of format
Critique of content
Workshop: Supplier Quality Agreement
Breakout groups to review and suggest improvement in supplier quality agreements.
For more information about this training visit https://www.researchandmarkets.com/r/lm11cq
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Best Practices for Supplier Qualification in Life Science Training Course
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025
Presentation to be webcast live at 10:00 AM ET NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: 'STSS' and 'STSSW') ('Sharps'), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present at the Virtual Investor Summit on June 10, 2025, at 10:00 AM ET. Investors are invited to listen to the presentation and can register here. Sharps recently announced that the Company has commenced shipments under three customer orders tied to previously announced purchase agreements. These shipments represent the Company's first commercial deliveries and its transition to revenue-generating operations. All products are being manufactured and shipped from Sharps' facility in Hungary, which has undergone significant upgrades to support high-volume production. Read the update release HERE. Presentation Details: Event: Q2 Investor Summit Date & Time: 10:00 AM ET on June 10, 2025 Presenter: Robert Hayes, CEO Webcast: LINK HERE Conference Overview and Structure:The Investor Summit is an exclusive event tailored for investors focused on small- and micro-cap stocks. It offers a unique opportunity to meet with management teams from high-potential emerging companies, gain insights from industry experts, and understand how peers are navigating the current market environment. This quarter's event centers on micro-cap companies that are currently undervalued and positioned near catalyst events that could significantly accelerate their growth trajectory. Registration for Investors:To request free registration, please go to the Investor Summit website, ( and click the "Registration" button. For More Information, please visit: or, contact johnna-mae@ About Sharps Technology:Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The Company has a manufacturing facility in Hungary. For additional information, please visit FORWARD-LOOKING STATEMENTS:This press release contains 'forward-looking statements'. Forward-looking statements reflect our current view about future events. When used in this press release, the words 'anticipate,' 'believe,' 'estimate,' 'expect,' 'future,' 'intend,' 'plan,' 'poised' or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity, and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Investor Contact:Holdsworth PartnersAdam HoldsworthPhone: 917-497-9287Email: IR@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
California Regional MLS Launches Property Guardian InsurAble to Help Agents Address Wildfire-Related Insurance Challenges
CHINO HILLS, Calif., June 9, 2025 /PRNewswire/ -- California Regional MLS (CRMLS), the most recognized multiple listing service in the nation, announced today the launch of Property Guardian InsurAble, a wildfire risk and insurance assessment tool, for all CRMLS users. In California's high-risk wildfire zones, insurance uncertainty is derailing real estate transactions. Buyers often discover too late that a property is uninsurable or prohibitively expensive to cover, causing deals to stall or fall apart. Property Guardian InsurAble empowers agents and buyers with the clarity they need before an offer is made to help keep transactions on track. "Wildfires have become an increasingly frequent and devastating threat across California, which means matters of insurance only get more complicated," said Art Carter, CEO of CRMLS. "Property Guardian's InsurAble tool helps CRMLS users have smarter conversations, protect their clients, and close with more certainty." Key capabilities include: Insurance availability at a glance – Understand how insurable a property is across admitted, excess & surplus, and FAIR Plan markets, with premium estimates and risk drivers. Customized mitigation guidance – Property-specific recommendations based on IBHS standards to reduce risk and potentially lower insurance costs. In-depth wildfire risk insights – Layered analysis of a property's wildfire vulnerability including structure, parcel, community, and regional factors, plus ember reach and historical wildfire footprints. Insurance support – Optional referral to a licensed insurance broker for quote assistance and expanded market access. "InsurAble is not just about identifying wildfire risk; it's about helping agents guide their clients through it," said Pat Blandford, Founder and CEO of Property Guardian. "By showing insurance availability upfront and connecting buyers to real broker support, agents can keep deals moving and help clients make smarter, more confident decisions." Built by wildfire mitigation experts, insurance underwriters, data scientists, and NFPA-certified firefighters, Property Guardian brings together advanced analytics with boots-on-the-ground expertise. Trusted by carriers, the tool now equips real estate professionals to be local experts on insurability and resilience. CRMLS users can access discounted Property Guardian InsurAble assessments now through the CRMLS Marketplace. About California Regional Multiple Listing Service (CRMLS)California Regional MLS is the nation's most recognized subscriber-based MLS, dedicated to servicing more than 100,000 real estate professionals from dozens of Associations, Boards, and MLS organizations. CRMLS is the industry powerhouse and thrives on providing the most relevant products and services to its subscribers. For more information on CRMLS, visit About Property Guardian Powered by Green Shield Risk Solutions, Property Guardian helps make the world more insurable through advanced technology, expert insights, and strategic partnerships. We deliver wildfire risk assessments, safety recommendations, and insurance solutions tailored to each property. Learn more at Media Contact: Art Carter, art@ View original content to download multimedia: SOURCE California Regional MLS Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Martinelli & Switzer LLC Launches 'The Replicate Program' to Help Visionary Leaders Expand Their Impact
Jupiter, Florida , June 09, 2025 (GLOBE NEWSWIRE) -- Martinelli & Switzer LLC today announced the launch of , a strategic initiative designed to empower professionals, coaches, and consultants to scale their unique methodologies through a network of certified practitioners. This six-month program provides structured support for thought leaders aiming to deliver their work to wider audiences by building and training aligned, capable teams. The Replicate Program helps experts certify others in their methods to scale impact and grow their influence. Structured around transformation and mentorship, offers participants a roadmap to replicate their intellectual property, codify their methods, and create business models that sustain their legacy and extend their reach. 'There's no doubt a certification or licensing program of your own would be a game-changer for your career.,' said Janet Switzer, co-creator of The Replicate Program. 'This initiative is about breaking through and building a network of certified individuals who understand, believe in, and can deliver your work at scale.' 'The Replicate Program was born from a realization that many thought leaders hit a ceiling—not because of their vision, but because of bandwidth,' said Paul Martinelli, co-creator of the The Replicate Program. Participants in will receive: A proven framework for duplicating and scaling intellectual property Weekly strategic guidance from experienced mentors Access to customizable training systems for new practitioners A clear roadmap for recruiting, certifying, and supporting practitioners Developed in response to growing demand from experts who feel limited by solo delivery models, The Replicate Program is already generating strong interest from professionals seeking to systematize their approach and amplify their impact. For more information, visit . About Martinelli & Switzer LLCMartinelli & Switzer LLC is a Jupiter, Florida-based consultancy focused on empowering leaders to expand their influence through structured programs and strategic development. Its flagship initiative, The Replicate Program, supports professionals in building certified practitioner networks that carry their legacy forward with precision and purpose. Press ContactMediaThe Replicate ProgramEmail: success@ 521 Bald Eagle Drive, Jupiter, FL 33477, USA The Replicate Program helps you certify others to multiply your impact and expand your reach. Sign in to access your portfolio